T0	KEYPHRASE-NOTYPES 26 33	species
T1	KEYPHRASE-NOTYPES 64 76	Lyme disease
T2	KEYPHRASE-NOTYPES 87 118	common tick-transmitted illness
T3	KEYPHRASE-NOTYPES 126 143	boreal hemisphere
T4	KEYPHRASE-NOTYPES 154 160	Europe
T5	KEYPHRASE-NOTYPES 162 174	Lyme disease
T6	KEYPHRASE-NOTYPES 265 267	US
T7	KEYPHRASE-NOTYPES 297 307	sole cause
T8	KEYPHRASE-NOTYPES 315 327	Lyme disease
T9	KEYPHRASE-NOTYPES 375 386	skin lesion
T10	KEYPHRASE-NOTYPES 388 404	erythema migrans
T11	KEYPHRASE-NOTYPES 416 428	several days
T12	KEYPHRASE-NOTYPES 432 437	weeks
T13	KEYPHRASE-NOTYPES 443 453	spirochete
T14	KEYPHRASE-NOTYPES 468 483	different sites
T15	KEYPHRASE-NOTYPES 493 503	meningitis
T16	KEYPHRASE-NOTYPES 516 535	peripheral neuritis
T17	KEYPHRASE-NOTYPES 537 545	carditis
T18	KEYPHRASE-NOTYPES 547 574	atrioventricular node block
T19	KEYPHRASE-NOTYPES 579 609	migratory musculoskeletal pain
T20	KEYPHRASE-NOTYPES 611 617	Months
T21	KEYPHRASE-NOTYPES 625 639	Lyme arthritis
T22	KEYPHRASE-NOTYPES 655 673	untreated patients
T23	KEYPHRASE-NOTYPES 688 697	infection
T24	KEYPHRASE-NOTYPES 706 717	rapid onset
T25	KEYPHRASE-NOTYPES 741 745	pain
T26	KEYPHRASE-NOTYPES 758 764	joints
T27	KEYPHRASE-NOTYPES 784 788	knee
T28	KEYPHRASE-NOTYPES 803 811	patients
T29	KEYPHRASE-NOTYPES 813 827	synovial fluid
T30	KEYPHRASE-NOTYPES 859 876	mononuclear cells
T31	KEYPHRASE-NOTYPES 890 898	patients
T32	KEYPHRASE-NOTYPES 900 914	Lyme arthritis
T33	KEYPHRASE-NOTYPES 947 977	intravenous antibiotic therapy
T34	KEYPHRASE-NOTYPES 991 1001	rare cases
T35	KEYPHRASE-NOTYPES 1003 1026	proliferative synovitis
T36	KEYPHRASE-NOTYPES 1044 1050	months
T37	KEYPHRASE-NOTYPES 1054 1063	treatment
T38	KEYPHRASE-NOTYPES 1069 1085	oral antibiotics
T39	KEYPHRASE-NOTYPES 1091 1096	month
T40	KEYPHRASE-NOTYPES 1100 1109	treatment
T41	KEYPHRASE-NOTYPES 1115 1138	intravenous antibiotics
T42	KEYPHRASE-NOTYPES 1154 1163	condition
T43	KEYPHRASE-NOTYPES 1174 1210	antibiotic-refractory Lyme arthritis
